Clinical outcomes of dogs with high-grade cutaneous mast cell tumors
ObjectivesTo evaluate the prognostic factors and treatment outcomes in dogs with high-grade cutaneous mast cell tumors (HGMCTs).MethodsMedical records of dogs with a histopathologic diagnosis of HGMCTs were reviewed from a single institution. Clinical factors, treatment-related variables, and adjuva...
Saved in:
| Main Authors: | Siew Mei Ong, Charly McKenna, Christopher Pinard, Danielle Richardson, Michelle L. Oblak |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-01-01
|
| Series: | Frontiers in Veterinary Science |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fvets.2024.1519636/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Prognostic significance of YKL-40 expression in canine cutaneous mast cell tumors
by: Chien-Chun Kuo, et al.
Published: (2024-11-01) -
Response to tigilanol tiglate in dogs with mast cell tumors
by: Margaret L. Musser, et al.
Published: (2024-11-01) -
Risk Factors for the Occurrence of Cutaneous Neoplasms in Dogs: A Retrospective Study by Cytology Reports, 2019–2021
by: Issa Carolina García-Reynoso, et al.
Published: (2025-07-01) -
Oxidative Status and Lipid Metabolism Analytes in Dogs with Mast Cell Tumors: A Preliminary Study
by: Argyrios Ginoudis, et al.
Published: (2024-11-01) -
Clinical differentiation of cutaneous and subcutaneous mast cell tumors in dogs: A pilot study
by: Teruo Itoh, et al.
Published: (2024-11-01)